Indrayani Biotech has revised the schedule for its Rights Issue. The period for eligible equity shareholders to apply for new shares will now open and close later than originally announced. Similarly, the final date for on-market renunciation of rights entitlements has also been extended. All other terms and conditions of the Rights Issue remain unchanged. Shareholders should note these updated timelines, as new application forms and related documents will be available for their reference on the company and stock exchange websites.